Cargando…

Altered Cholesterol Homeostasis in Huntington’s Disease

Huntington’s disease (HD) is an autosomal dominant genetic disorder caused by an expansion of the CAG repeat in the first exon of Huntingtin’s gene. The associated neurodegeneration mainly affects the striatum and the cortex at early stages and progressively spreads to other brain structures. Target...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kacher, Radhia, Mounier, Coline, Caboche, Jocelyne, Betuing, Sandrine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063567/ https://www.ncbi.nlm.nih.gov/pubmed/35517051 http://dx.doi.org/10.3389/fnagi.2022.797220

Ejemplares similares

Multiple Aspects of Gene Dysregulation in Huntington’s Disease
por: Moumné, Lara, et al.
Publicado: (2013)

Huntington’s Disease and Striatal Signaling
por: Roze, Emmanuel, et al.
Publicado: (2011)

Cell-Type Specific Regulation of Cholesterogenesis by CYP46A1 Re-Expression in zQ175 HD Mouse Striatum
por: Pinchaud, Katleen, et al.
Publicado: (2023)

CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease
por: Boussicault, Lydie, et al.
Publicado: (2016)

Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter
por: Martin, Elodie, et al.
Publicado: (2011)

The cholesterol 24-hydroxylase activates autophagy and decreases mutant huntingtin build-up in a neuroblastoma culture model of Huntington’s disease
por: Nóbrega, Clévio, et al.
Publicado: (2020)

Propensity for somatic expansion increases over the course of life in Huntington disease
por: Kacher, Radhia, et al.
Publicado: (2021)

Editorial: Cholesterol and Neurodegenerative Diseases - Pressing Questions and How to Address Them
por: Betuing, Sandrine, et al.
Publicado: (2022)

Dopamine D2 Receptor Stimulation Potentiates PolyQ-Huntingtin-Induced Mouse Striatal Neuron Dysfunctions via Rho/ROCK-II Activation
por: Deyts, Carole, et al.
Publicado: (2009)

Elk-1 a Transcription Factor with Multiple Facets in the Brain
por: Besnard, Antoine, et al.
Publicado: (2011)

Alterations in metal homeostasis occur prior to canonical markers in Huntington disease
por: Pfalzer, Anna C., et al.
Publicado: (2022)

Distinct histological alterations of cortical interneuron types in mouse models of Huntington’s disease
por: Voelkl, Kerstin, et al.
Publicado: (2022)

Altered Intracortical T(1)-Weighted/T(2)-Weighted Ratio Signal in Huntington’s Disease
por: Rowley, Christopher D., et al.
Publicado: (2018)

Mood disorders in Huntington's disease: from behavior to cellular and molecular mechanisms
por: Pla, Patrick, et al.
Publicado: (2014)

Altered Balance of Activity in the Striatal Direct and Indirect Pathways in Mouse Models of Huntington's Disease
por: André, Véronique M., et al.
Publicado: (2011)

Disrupting D1-NMDA or D2-NMDA receptor heteromerization prevents cocaine’s rewarding effects but preserves natural reward processing
por: Andrianarivelo, Andry, et al.
Publicado: (2021)

Altered Levels and Isoforms of Tau and Nuclear Membrane Invaginations in Huntington’s Disease
por: Fernández-Nogales, Marta, et al.
Publicado: (2020)

Acanthocytes Identified in Huntington’s Disease
por: Yu, Yueyi, et al.
Publicado: (2022)

Contribution of Neuroepigenetics to Huntington’s Disease
por: Francelle, Laetitia, et al.
Publicado: (2017)

Pitfalls in the detection of cholesterol in Huntington’s disease models
por: Marullo, Manuela, et al.
Publicado: (2012)

The Alteration of Emotion Regulation Precedes the Deficits in Interval Timing in the BACHD Rat Model for Huntington Disease
por: Garces, Daniel, et al.
Publicado: (2018)

Differential Alteration in Expression of Striatal GABA(A)R Subunits in Mouse Models of Huntington’s Disease
por: Du, Zhuowei, et al.
Publicado: (2017)

Developmental Whole Brain White Matter Alterations in Transgenic Huntington’s Disease Monkey
por: Meng, Yuguang, et al.
Publicado: (2017)

Targeting Cholesterol Homeostasis to Fight Hearing Loss: A New Perspective
por: Malgrange, Brigitte, et al.
Publicado: (2015)

Cannabinoid signaling and risk in Huntington's disease
por: Humble, James, et al.
Publicado: (2022)

Commentary: Acanthocytes identified in Huntington's disease
por: Peikert, Kevin, et al.
Publicado: (2022)

Corticostriatal Dysfunction in Huntington’s Disease: The Basics
por: Bunner, Kendra D., et al.
Publicado: (2016)

Microglial Activation in the Pathogenesis of Huntington’s Disease
por: Yang, Hui-Ming, et al.
Publicado: (2017)

Cortical and Striatal Circuits in Huntington’s Disease
por: Blumenstock, Sonja, et al.
Publicado: (2020)

The Role of Microglia and Astrocytes in Huntington’s Disease
por: Palpagama, Thulani H., et al.
Publicado: (2019)

Alterations in the homeostasis of phospholipids and cholesterol by antitumor alkylphospholipids
por: Jiménez-López, José M, et al.
Publicado: (2010)

Proprotein Convertase Subtilisin/Kexin Type 9, Brain Cholesterol Homeostasis and Potential Implication for Alzheimer’s Disease
por: Adorni, Maria Pia, et al.
Publicado: (2019)

Altered Expression of Matrix Metalloproteinases and Their Endogenous Inhibitors in a Human Isogenic Stem Cell Model of Huntington's Disease
por: Naphade, Swati, et al.
Publicado: (2018)

Altered Mitochondrial Protein Homeostasis and Proteinopathies
por: Jishi, Aya, et al.
Publicado: (2022)

Role of cerebral cortex in the neuropathology of Huntington's disease
por: Estrada-Sánchez, Ana M., et al.
Publicado: (2013)

Motor–Language Coupling in Huntington’s Disease Families
por: Kargieman, Lucila, et al.
Publicado: (2014)

Ubiquitin–proteasome system involvement in Huntington’s disease
por: Ortega, Zaira, et al.
Publicado: (2014)

Huntingtin Aggregates in the Olfactory Bulb in Huntington’s Disease
por: Highet, Blake, et al.
Publicado: (2020)

Purinergic Signaling in the Pathophysiology and Treatment of Huntington’s Disease
por: Wiprich, Melissa Talita, et al.
Publicado: (2021)

Pain in Huntington’s disease and its potential mechanisms
por: Li, Jiajie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5n4b1g7d80mhq80ttp8478nvdm